Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Recalled August 9, 2023 · FDA recall D-1049-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: Lack of validation data for sanitization cycles · FDA Class II
Units
2,228 syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Product
HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →